We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Btg Plc | LSE:BTG | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 840.00 | 839.00 | 840.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2016 20:04 | I suspect that it's only the spectre of takeover activity in the drug sector that is going to result in a meaningful revival in the share price over the next half year..Both BTG and for that matter,the likes of Astra Zeneca and Glaxo have their sceptics and that's weighing on the price.The latter two are suffering from a flight from bond proxy dividend stocks in the USA which is unlikely to quickly reverse.It's too late to sell perhaps given that BTG shares are flirting with a 52 week low but I think the management should start to pay attention to what the market is saying,forget the drug analysts,they are invariably slow to react to sector rotation.The market feels the BTG rating is quite high enough for a stock that has failed to exceed best expectations....and when you're on a BTG style rating,you need to surprise on the upside....and they're not.Of course,currency losses don't aid the cause. Technical comment on Barclays website- Short term comment Losses from the last relative highs set at 7.28 makes the long-term bullish scenario to be recently discarded. Very short-term falls restrainment gives a positive signal that will remain as long as it doesn't lose support at 5.71. Next support is 556p apparently | steeplejack | |
05/12/2016 10:12 | Another brick in the wall for copd sufferers! | fhmktg | |
02/12/2016 13:43 | Investors are tiring of companies like BTG and Vectura which promise jam tomorrow, have good revenue, plenty of cash, decent products but pay zilch in return save to bod and employees after years of the same hogwash. With rising bond yields and cos like pfc, ved or mks with equally good growth prospects and divis there is plenty more downside for these beauties. And their products are not risk free, being very small fish in a very large pond. imo | cumnor | |
01/12/2016 16:23 | Louis and her team issueing and issueing options and warrants for great performance-its disaster - they should fired imo Its time to renew this management - they stink | a1ord53 | |
01/12/2016 14:00 | Oh dear, I'm in again at 5.71. We now know the names of the men in shiny suits and dirty underpants, or at least the American ones. As expected they're far from being Masters of the Universe in their recent performance. Let us hope that our gains will be their losses. It's always been a zero-sum game between us and them, hasn't it? BTW it's about time Woodford bought some BTG again for WPCT. | muffmitz | |
01/12/2016 13:50 | Sorry: some unintended dittography. See below | muffmitz | |
30/11/2016 20:27 | This shorting has cost me over £100k! | fhmktg | |
30/11/2016 20:26 | So, we send 'the boys' round to 'short them out' ? | fhmktg | |
30/11/2016 16:56 | shorttracker.co.uk/c | a1ord53 | |
30/11/2016 16:56 | link to site shorttracker.co.uk/c | a1ord53 | |
29/11/2016 17:38 | Should have put 25 p on the share price per leg Greg. | bargainbob | |
29/11/2016 16:24 | At last! Well spotted ! | fhmktg | |
29/11/2016 16:14 | This came out on 17th November. Don't know how many have seen it. | gregsc | |
29/11/2016 14:28 | Yes,Wall Street is dictating that defensives can be sold in favour of cyclicals on the premise of accelerating GNP growth and higher inflation.Ten year treasuries now provide a yield of around 2.3%.Ultimately,the growth scenario is uncertain but without a yield,BTG is feeling the full draft of a weak pharma sector.May as well ride this one out for now. | steeplejack | |
29/11/2016 13:39 | --> dp1ump You might be grateful one day that you have smaller balls! ;) | spyder | |
29/11/2016 13:29 | Agree getting very bored and a little nervous,if I had bigger balls I would switch my holding here into vectura who are gaining a little momentum.But to be honest the whole pharma sector is being sold off. | dp1umb | |
29/11/2016 12:29 | That makes me feel better! | fhmktg | |
29/11/2016 12:29 | Not a penny lost either!! :) | spyder | |
29/11/2016 12:12 | Not a penny made since February 2014-this is hurting! | fhmktg | |
26/11/2016 18:01 | Interesting , they could have done that or for backing of a third party approach. Certainty looks strange on the surface. Though the price weakness suggests someone shorted it. Why would Aviva do that though. | bargainbob | |
25/11/2016 23:37 | Did u see todays announcement holding in Btg by Aviva ? Question : Did they loan 8 mil shares ? ... to short sellers ? Could anybody explain ? | a1ord53 | |
23/11/2016 20:40 | Spyder , A return to the low £5 is possible , really surprised how often this happens and BTG attracts zero bidders. | bargainbob | |
23/11/2016 15:25 | I have today bought for my own portfolio and my grandchilren's ISAs. It may not be the bottom but it's a great opportunity for the medium term. Usual caveats. | muffmitz |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions